Cargando…
Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming
Cardiovascular disease is the leading cause of death globally. Cardiomyocytes (CMs) have poor regenerative capacity, and pharmacological therapies have limited efficacy in severe heart failure. Currently, there are several promising strategies for cardiac regeneration. The most promising approach to...
Autor principal: | Sadahiro, Taketaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606831/ https://www.ncbi.nlm.nih.gov/pubmed/31304202 http://dx.doi.org/10.1016/j.reth.2019.06.004 |
Ejemplares similares
-
Direct Cardiac Reprogramming ― Converting Cardiac Fibroblasts to Cardiomyocytes ―
por: Sadahiro, Taketaro
Publicado: (2019) -
Direct Cardiac Reprogramming: A Novel Approach for Heart Regeneration
por: Tani, Hidenori, et al.
Publicado: (2018) -
Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Park, Misun, et al.
Publicado: (2018) -
A biomimetic hydrogel culture system to facilitate cardiac reprogramming
por: Kurotsu, Shota, et al.
Publicado: (2022) -
Heart regeneration for clinical application update 2016: from induced pluripotent stem cells to direct cardiac reprogramming
por: Yamakawa, Hiroyuki
Publicado: (2016)